Ochre Bio announces partnership with Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease April 22, 2024
Ochre Bio Strengthens Leadership Team and Board of Directors with Liver Disease Translational Expertise April 5, 2023
Ochre Bio Announces Formation of Scientific Strategy Board with Liver Disease Experts October 20, 2022